Abstract
Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Current Molecular Medicine
Title:Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19
Volume: 21 Issue: 6
Author(s): Christine Ibrahim, Hanna Semaan, Marwan El-Sabban*, Fadia Najjar*Aline Hamade*
Affiliation:
- Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
- Laboratoire d’Innovation Thérapeutique, Departments of Biology, Chemistry and Biochemistry, Lebanese University, Faculty of Sciences II, Fanar,Lebanon
Keywords: Coronavirus, COVID-19, stem cells, cytokine storm, lung injuries, immunomodulatory effect.
Abstract: Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2) is an extremely pathogenic virus belonging to the family of Coronaviridae. First identified in Wuhan, China in December 2019 after an epidemiological investigation of an emerging cluster of pneumonia of unknown etiology, SARS-CoV-2 was declared the cause of a pandemic on March 11 by the World Health Organization (WHO), pointing to the over 118000 cases of Coronavirus disease 2019 (COVID-19) in over 110 countries. Despite the promising results of drug repositioning studies in the treatment of COVID-19, the evidence of their safety and efficacy remains inconclusive. Cell based therapy has been proven safe and possibly effective in treating multiple lung injuries and diseases, but its potential use in the treatment of COVID-19 has not been yet elucidated. Our aim in this review is to provide an overview of the immunomodulatory effect and the regenerative capacity of stem cells and their secretome in the treatment of many diseases including lung injuries. Those findings may contribute to a better understanding of the potential of stem cell therapy in SARS-CoV-2 infection and its potential use in order to find a solution for this healthcare crisis.
Export Options
About this article
Cite this article as:
Ibrahim Christine , Semaan Hanna , El-Sabban Marwan *, Najjar Fadia *, Hamade Aline *, Addressing the Importance of Stem Cell-Based Therapy: A Perspective in the Treatment of COVID-19, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201117120147
DOI https://dx.doi.org/10.2174/1566524020999201117120147 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
NLRP3 Is Involved in Ischemia/Reperfusion Injury
CNS & Neurological Disorders - Drug Targets Novel Heterocyclic Hybrids Based on 2-Pyrazoline: Synthesis and Assessment of Anti-Inflammatory and Analgesic Activities
Current Organic Synthesis Patent Ductus Arteriosus in Extreme Prematurity: Role of Echocar-diography and Other Imaging Techniques
Current Pediatric Reviews A Plant-Defensin from Sugarcane (Saccharum spp.)
Protein & Peptide Letters EDITORIAL: Repurposing Niacin as Antiplatelet Drug?
Current Clinical Pharmacology Invasive aspergillosis: adjunctive combination therapy
Mini-Reviews in Medicinal Chemistry Cardiac Remodeling Induced by Smoking: Concepts, Relevance, and Potential Mechanisms
Inflammation & Allergy - Drug Targets (Discontinued) Immunosuppressive Drugs in HIV Disease
Current Topics in Medicinal Chemistry Lipid Nanoparticles for the Delivery of Biopharmaceuticals
Current Pharmaceutical Biotechnology Is there Any Correlation Between Binding and Functional Effects at the Translocator Protein (TSPO) (18 kDa)?
Current Molecular Medicine Patent Selections
Recent Patents on Drug Delivery & Formulation Biodegradable Guar Gum Based Hydrogel for Pharmaceutical Application
Current Chemical Biology Gene Therapy of Cancer with Interleukin-12
Current Pharmaceutical Design Chronic Inflammation in the Pancreas and Salivary Glands - Lessons from Similarities and Differences in Pathophysiology and Treatment Modalities
Current Pharmaceutical Design A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems
Pharmaceutical Nanotechnology Epigenetic Modifications: New Therapeutic Targets in Primary Myelofibrosis
Current Stem Cell Research & Therapy PET Imaging for Gene & Cell Therapy
Current Gene Therapy MicroRNAs as Potential Therapeutic Agents in the Treatment of Myocardial Infarction
Current Vascular Pharmacology Membrane Transporters in Physiological Barriers of Pharmacological Importance
Current Pharmaceutical Design Monocytes, Macrophages and Other Inflammatory Mediators of Abdominal Aortic Aneurysm
Current Pharmaceutical Design